1. Serum galectin-3 concentrations in patients with ankylosing spondylitis
- Author
-
Ya-Bin Hu, Xiao-Liang Gao, Jiang Wang, and Ming-Yu Cao
- Subjects
0301 basic medicine ,Microbiology (medical) ,Adult ,Male ,medicine.medical_specialty ,Schmidt sting pain index ,Galectin 3 ,Galectins ,Clinical Biochemistry ,Blood Sedimentation ,Gastroenterology ,03 medical and health sciences ,0302 clinical medicine ,Disease severity ,Internal medicine ,ankylosing spondylitis ,Immunology and Allergy ,Medicine ,Humans ,In patient ,Spondylitis, Ankylosing ,Research Articles ,serum galectin‐3 ,Galectin ,Ankylosing spondylitis ,ASDAS index ,medicine.diagnostic_test ,business.industry ,Biochemistry (medical) ,Public Health, Environmental and Occupational Health ,Hematology ,Blood Proteins ,medicine.disease ,Medical Laboratory Technology ,030104 developmental biology ,C-Reactive Protein ,Galectin-3 ,030220 oncology & carcinogenesis ,Erythrocyte sedimentation rate ,Case-Control Studies ,Linear Models ,Multiple linear regression analysis ,Female ,business ,Biomarkers ,Research Article - Abstract
Objective The aim of our study was to assess potential correlations between serum galectin‐3 concentrations and Ankylosing Spondylitis Disease Activity (ASDAS) index in patients with ankylosing spondylitis (AS). Methods A total of 112 patients with AS were included, and 130 healthy subjects were considered as controls. We collected the detailed medical history, and ASDAS index was used to assess the disease severity in patients with AS. Results The serum galectin concentrations were higher in AS patients compared to the health groups (14.1 ± 9.6 vs 9.2 ± 3.7, P
- Published
- 2019